Sparfloxacin: a review.

@article{Schentag2000SparfloxacinAR,
  title={Sparfloxacin: a review.},
  author={Jerome J. Schentag},
  journal={Clinical therapeutics},
  year={2000},
  volume={22 4},
  pages={372-87; discussion 371}
}
BACKGROUND The continuing increase in the rate of penicillin and cephalosporin resistance among respiratory pathogens and of cross-resistance to macrolide antibiotics has led to the recommendation that fluoroquinolone antibiotics be used to treat high-risk patients with community-acquired pneumonia (CAP) and acute bacterial exacerbations of chronic… CONTINUE READING